← All trials
NCT01592526
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2012
- Primary completion
- Jan 31, 2013
- Completion date
- Dec 31, 2015
- First posted
- May 7, 2012
- Last posted
- Jan 29, 2016
- Enrollment
- 23
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of CopenhagenLead sponsor
- University of CopenhagenCollaborator
- University of CopenhagenReponsible party - principal investigator
- University of CopenhagenStudy director
- University of CopenhagenSponsor investigator
- University of CopenhagenOfficial
- University of CopenhagenOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.